Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Oct 27;391(1):37–49. doi: 10.1007/s00210-017-1431-y

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2017

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

PMC Copyright notice

Fig. 1 — Effects of EMD386088 and antidepressants given alone or in combination in the modified FST in rats. a Effects of EMD386088 and imipramine in the FST. b Effects of EMD386088 and reboxetine in the FST. c Effects of EMD386088 and moclobemide in the FST. d Effects of EMD386088 and bupropion in the FST. e Effects of EMD386088 and s-citalopram in the FST. EMD386088, imipramine, and s-citalopram were injected i.p. 30 min, while reboxetine, moclobemide, and bupropion were given i.p. 60 min before the test. Values represent the mean ± SEM and were analyzed by two-way ANOVA followed by Bonferroni’s post hoc test: *p < 0,05, **p < 0.01, ***p < 0.001relative to respective vehicle group; ###p < 0.001, ####p < 0.0001 relative to respective group receiving non-active dose of respective antidepressant drug without EMD386088, N = 6–8